BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25754855)

  • 1. Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.
    Adamus G
    Invest Ophthalmol Vis Sci; 2015 Mar; 56(3):1680-8. PubMed ID: 25754855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
    Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
    Adamus G; Ren G; Weleber RG
    BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy.
    Adamus G; Champaigne R; Yang S
    Clin Immunol; 2020 Jan; 210():108317. PubMed ID: 31770612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune retinopathy and antiretinal antibodies: a review.
    Grewal DS; Fishman GA; Jampol LM
    Retina; 2014 May; 34(5):827-45. PubMed ID: 24646664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated retinopathy in patients with breast carcinoma.
    Misiuk-Hojło M; Ejma M; Gorczyca WA; Szymaniec S; Witkowska D; Fortuna W; Miedzybrodzki R; Rogozińska-Szczepka J; Bartnik W
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):261-5. PubMed ID: 17659379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Müller cell-specific autoantibodies in a patient with progressive loss of vision.
    Peek R; Verbraak F; Coevoet HM; Kijlstra A
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1976-9. PubMed ID: 9727423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies?
    Adamus G
    Front Immunol; 2018; 9():765. PubMed ID: 29713325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss.
    Carboni G; Forma G; Bond AD; Adamus G; Iannaccone A
    Doc Ophthalmol; 2012 Aug; 125(1):63-70. PubMed ID: 22569848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.
    Khan N; Huang JJ; Foster CS
    Semin Ophthalmol; 2006; 21(3):135-41. PubMed ID: 16912011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
    Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
    Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy.
    Peek R; Dijkstra BG; Meek B; Kuijpers RW
    Clin Exp Immunol; 2002 Jun; 128(3):498-503. PubMed ID: 12067305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive Auto-Antibody Activity With Retina and Optic Nerve in Smokers and Non-Smokers: The Controversy Continues.
    Chin EK; Almeida DR; Lam KV; Keltner JL; Thirkill CE
    Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):1068-70. PubMed ID: 26599255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Correlation between Number of Antiretinal Antibodies and Clinical Outcome Measures in Autoimmune Retinopathy Patients.
    Stanwyck LK; Moussa K; Chan W; Aitken PA; Sobrin L
    Ophthalmol Retina; 2019 Nov; 3(11):1007-1009. PubMed ID: 31420299
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
    Guy J; Aptsiauri N
    Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
    Dot C; Guigay J; Adamus G
    Am J Ophthalmol; 2005 Apr; 139(4):746-7. PubMed ID: 15808190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcinoma-associated retinopathy: a review with clinical examples].
    Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slowly progressive non-neoplastic autoimmune-like retinopathy.
    Ohta K; Kikuchi T; Yoshida N
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):155-8. PubMed ID: 20625760
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.
    Adamus G
    Autoimmun Rev; 2009 Mar; 8(5):410-4. PubMed ID: 19168157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.